Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSafestore Regulatory News (SAFE)

Share Price Information for Safestore (SAFE)

Share Price is delayed by 15 minutes
Get Live Data
630.50    10.00 (1.61%)
Bid:
628.50
Ask:
629.00
Spread: 0.50 (0.08%)
Market Cap: £1.38b
SAFE Live PriceLast checked at - London Stock Exchange

Intraday Safestore Share Chart

Placing

18 Mar 2010 07:00

RNS Number : 7636I
Bridgepoint Capital Ltd
18 March 2010
 

Bridgepoint Capital Ltd

18 March 2010

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR IN OR FROM THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

Bridgepoint Capital Ltd partial disposal of interest in Safestore Holdings plc

18 March 2010

Bridgepoint Capital Ltd ("Bridgepoint") announces today that it intends to offer for sale up to 32 million ordinary shares of 1 pence each (the 'Shares') in the capital of Safestore Holdings plc ("Safestore" or the "Company"). This represents, in aggregate, up to a maximum of 17.0 per cent. of the current issued ordinary share capital of Safestore. Bridgepoint will continue to hold at least 17.9 per cent of the current issued ordinary share capital of Safestore post this transaction. Bridgepoint have committed, subject to limited carve outs, to not sell further shares in Safestore for a period of 90 days from this announcement.

The offering will be effected by way of an accelerated bookbuilt offering (the 'Placing') to be launched immediately following this announcement. J.P. Morgan Cazenove has been appointed Sole Bookrunner in respect of the Placing. The placing price of the Shares will be determined at the close of the bookbuild and announced shortly thereafter.

Contacts:

Bridgepoint Capital Ltd

James Murray +44 (0)20 7432 3555

 

J.P. Morgan Cazenove

Laurence Hollingworth +44 (0)20 7155 5000

Nicholas Hall +44 (0)20 7155 5000

THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES ARE ONLY ADDRESSED TO AND DIRECTED AT PERSONS WHO (1) IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA ARE QUALIFIED INVESTORS WITHIN THE MEANING OF DIRECTIVE 2003/71/EC AND ANY RELEVANT IMPLEMENTING MEASURES (THE 'PROSPECTUS DIRECTIVE'); (2) IN THE UK HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN ARTICLE 19(1) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) (THE 'ORDER'); OR (3) IN THE UK ARE PERSONS FALLING WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER (ALL SUCH PERSONS REFERRED TO IN (1), (2) AND (3) TOGETHER BEING REFERRED TO AS 'RELEVANT PERSONS'). THE INFORMATION REGARDING THE PLACING SET OUT IN THIS ANNOUNCEMENT MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

This announcement has been issued by Bridgepoint and is the sole responsibility of Bridgepoint. 

This announcement and the information contained herein is for information purposes only and does not constitute or form part of any offer or an invitation to acquire or dispose of securities in the United States, Canada, Australia or Japan or in any other jurisdiction in which such an offer of solicitation is unlawful. 

The Shares have not been, and will not be, registered under the Securities Act or under the securities laws of any State or other jurisdiction of the United States, and, absent registration, may not be offered or sold in the United States or to a U.S. person (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or as part of a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any State or other jurisdiction of the United States. There will be no public offering of securities in the United States or elsewhere.

Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by any of Bridgepoint, J.P. Morgan Cazenove or their respective affiliates.

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in or into or from the United States, Canada, Australia or Japan. Any failure to comply with this restriction may constitute a violation of United States, Canadian, Australian or Japanese securities laws.

The distribution of this announcement and the offering or sale of the Shares in certain jurisdictions may be restricted by law. No action has been taken by Bridgepoint or J.P. Morgan Cazenove or any of their respective affiliates that would, or which is intended to, permit a public offer of the Shares in any jurisdiction or possession or distribution of this announcement or any other offering or publicity material relating to the Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by Bridgepoint and J.P. Morgan Cazenove to inform themselves about and to observe any such restrictions.

J.P. Morgan Cazenove is acting for Bridgepoint only in connection with the Placing, and no one else, and will not be responsible to anyone other than Bridgepoint for providing the protections offered to clients of J.P. Morgan Cazenove nor for providing advice in relation to the Placing.

J.P. Morgan Cazenove is a marketing name used by J.P. Morgan Securities Ltd.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDGGDXRXBBGGR
Date   Source Headline
18th Mar 202412:01 pmRNSHolding(s) in Company
15th Mar 20244:00 pmRNSDirector/PDMR Shareholding
13th Mar 20242:46 pmRNSResult of AGM
29th Feb 20241:48 pmRNSTotal Voting Rights
29th Feb 20241:45 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSAppointment of CFO
22nd Feb 20247:00 amRNSFirst quarter trading update
15th Feb 20241:46 pmRNSBlock listing Interim Review
13th Feb 202412:01 pmRNSPublication of Annual Report and Notice of Meeting
6th Feb 20243:19 pmRNSNotice of First Quarter Trading Update
6th Feb 20242:52 pmRNSDirector/PDMR Shareholding
31st Jan 20245:00 pmRNSTotal Voting Rights
30th Jan 202411:30 amRNSBlock Listing of Ordinary Shares
25th Jan 202411:13 amRNSDirectorate Change
17th Jan 20247:00 amRNSFinal Results
29th Dec 20239:56 amRNSTotal Voting Rights
6th Dec 20237:00 amRNSNotice of Final Results
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSFourth Quarter Trading Update
8th Nov 20237:01 amRNSDirector Declaration
8th Nov 20237:00 amRNSDirector/PDMR Shareholding (Correction)
2nd Nov 20237:00 amRNSNotice of Fourth Quarter Trading Update
1st Nov 20232:02 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTotal Voting Rights and Capital
28th Sep 20237:00 amRNSCFO Retirement
25th Sep 20237:00 amRNSHolding(s) in Company
11th Sep 202311:30 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSThird Quarter Trading Update
24th Aug 202312:30 pmRNSNotice of Third Quarter Trading Update
15th Aug 202311:15 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Jul 20239:45 amRNSDirectorate Change
14th Jul 20238:00 amRNSDirector/PDMR Shareholding
12th Jul 20235:40 pmRNSResult of General Meeting
28th Jun 202310:30 amRNSDirector/PDMR Shareholding
23rd Jun 20239:15 amRNSDirector/PDMR Shareholding
21st Jun 20233:15 pmRNSHolding(s) in Company
19th Jun 20233:45 pmRNSNotice of General Meeting
14th Jun 20237:00 amRNSHalf-year Report
13th Jun 20235:45 pmRNSHolding(s) in Company
2nd May 20232:30 pmRNSHolding(s) in Company
2nd May 20231:30 pmRNSTotal Voting Rights and Capital
21st Apr 20233:20 pmRNSDirectorate Change and Committee Composition
21st Apr 20231:45 pmRNSNotice of Interim Results
6th Apr 20237:00 amRNSHolding(s) in Company
3rd Apr 20233:05 pmRNSTotal Voting Rights and Capital
24th Mar 20235:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20238:30 amRNSBlock Listing of Ordinary Shares
16th Mar 20234:35 pmRNSDirector/PDMR Shareholding
15th Mar 20236:00 pmRNSResult of AGM
2nd Mar 20235:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.